SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2152445

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2152445

Cerebral Spinal Fluid Management Market Size, Share & Trends Analysis Report By Product (CSF Shunts, By CSF Drainage), By Valve (Adjustable Valve Shunts), By Type, By Age, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

The global cerebral spinal fluid management market size was valued at USD 724.2 million in 2025 and is projected to grow from USD 761.9 million in 2026 to USD 1,100 million in 2033, at a CAGR of 5.4% from 2026 to 2033. Cerebrospinal fluid, an ultrafiltrate of plasma found in the brain's ventricles, plays crucial roles in supplying nutrients, removing waste, and protecting the brain. Accumulation of excessive cerebrospinal fluid in the brain's cavities can lead to conditions such as hydrocephalus. Market growth is driven by the rising need for cerebrospinal fluid (CSF) management to treat Hydrocephalus and other brain-related disorders worldwide.

Market growth is primarily driven by the rising incidence of neurological disorders, such as hydrocephalus and meningitis, which require effective cerebrospinal fluid (CSF) management solutions. In addition, advancements in medical technology have significantly contributed to this growth by enabling the development of more efficient, less invasive treatment methods. The rising geriatric population, which is more vulnerable to neurological conditions, further boosts market demand.

Moreover, the medical device sector is experiencing rapid growth and innovation due to the increasing prevalence of neurological diseases. This trend presents significant opportunities for the industry, as key players are introducing new products featuring advanced technology, which is expected to positively impact market growth.

The CSF management market is also anticipated to expand due to the high potential for technology adoption in developing countries. This is driven by the rising prevalence of CSF-related disorders, the increasing number of market participants, and the growing demand for effective CSF management solutions. Furthermore, the healthcare industry in emerging economies is rapidly developing, supported by government investments in medical technology and the establishment of robust medical device industries.

Global Cerebral Spinal Fluid Management Market Report Segmentation

This report forecasts revenue growth at product, age group, and country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the cerebral spinal fluid management market report based on product, valve, type, age group, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

CSF Shunts

CSF Drainage

  • Valve Outlook (Revenue, USD Million, 2021 - 2033)

Adjustable Valve Shunts

Mono-pressure Valve Shunts

  • Type Outlook (Revenue, USD Million, 2021 - 2033)

Ventriculoperitoneal (VP) Shunts

Ventriculoatrial (VA) Shunts

Lumboperitoneal (LP) Shunts

Ventriculopleural (VPL) Shunts

  • Age Group Outlook (Revenue, USD Million, 2021 - 2033)

Adult

Pediatric

  • Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand

Latin America

    • Brazil
    • Argentina

Middle East and Africa (MEA)

    • Saudi Arabia
    • UAE
    • South Africa
    • Kuwait
Product Code: GVR-1-68038-373-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cerebral Spinal Fluid Management Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Cerebral Spinal Fluid Management Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Cerebral Spinal Fluid Management Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Cerebral Spinal Fluid Management Market: Product Movement Analysis, USD Million, 2025 & 2033
  • 4.3. CSF Shunts
    • 4.3.1. CSF Shunts Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. CSF Drainage
    • 4.4.1. CSF Drainage Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cerebral Spinal Fluid Management Market: Valve Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Cerebral Spinal Fluid Management Market: Valve Movement Analysis, USD Million, 2025 & 2033
  • 5.3. Adjustable Valve Shunts
    • 5.3.1. Adjustable Valve Shunts Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Mono-pressure Valve Shunts
    • 5.4.1. Mono-pressure Valve Shunts Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cerebral Spinal Fluid Management Market: Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Cerebral Spinal Fluid Management Market: Type Movement Analysis, USD Million, 2025 & 2033
  • 6.3. Ventriculoperitoneal (VP) Shunts
    • 6.3.1. Ventriculoperitoneal (VP) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Ventriculoatrial (VA) Shunts
    • 6.4.1. Ventriculoatrial (VA) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Lumboperitoneal (LP) Shunts
    • 6.5.1. Lumboperitoneal (LP) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ventriculopleural (VPL) Shunts
    • 6.6.1. Ventriculopleural (VPL) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cerebral Spinal Fluid Management Market: Age Group Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Cerebral Spinal Fluid Management Market: Age Group Movement Analysis, USD Million, 2025 & 2033
  • 7.3. Adult
    • 7.3.1. Adult Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Pediatric
    • 7.4.1. Pediatric Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Cerebral Spinal Fluid Management Market: Regional Estimates & Trend Analysis

  • 8.1. Cerebral Spinal Fluid Management Market Share, By Region, 2025 & 2033, USD Million
  • 8.2. North America
    • 8.2.1. North America Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. B. Braun Melsungen AG
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Integra LifeSciences Corporation
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Spiegelberg GmbH & Co. KG
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Medtronic
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Sophysa
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Beckersmith Medical, Inc
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Natus Medical Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Elekta AB
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Phoenix Biomedical Corp.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!